Walgreens eye drops recalled over sterility concerns
Key Points:
- Sterling Pharmaceutical Services LLC has recalled nearly 750,000 eye-care products, including over 500,000 Walgreens-branded eye-drop units, due to concerns about sterility.
- The FDA classified the recall as Class II, indicating that exposure to the affected products may cause temporary or medically reversible health effects, with serious consequences considered unlikely.
- The recall encompasses various brands such as AvKare, Reliable-1 Laboratories, Cameron Pharmaceuticals, TRP The Relief Products, and Major, affecting multiple types of lubricant eye drops and ointments.
- The FDA emphasizes the importance of sterility in ophthalmic products since eye applications bypass the body's natural defenses, increasing the risk of infection.
- Walgreens has not yet provided a comment regarding the recall.